Document is current
Any future updates will be listed below
-
Authors
Adair, Olivia https://orcid.org/0000-0002-1870-3818
McFerran, Ethna https://orcid.org/0000-0002-8918-7822
Lawler, Mark https://orcid.org/0000-0002-3930-8470
van Duuren, Luuk A. https://orcid.org/0000-0002-6286-8062
Lamrock, Felicity https://orcid.org/0000-0002-8395-2415
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 23 November 2025
First Online: 4 January 2026
Declarations
:
: The authors declare no competing interests. ML declares honoraria from Bayer, Carnall Farrar, EMD Serono, Novartis, Pfizer and Roche unrelated to this work. EMcF declares honoraria from Gilead Sciences unrelated to this work.
: Data may be available upon reasonable request from the corresponding author.
: Not applicable.
: Not applicable.
: Not applicable.
: Data are available on request from the corresponding author.
: OA undertook the role of lead author for this article, with FL as senior author. OA and FL developed the model structure. OA built the natural history and cost-effectiveness model in R. FL validated model code. All authors read, edited and approved the final version.
